Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs
Volume
9
Pagination
348 - +
DOI
10.1161/CIRCOUTCOMES.115.002592
Journal
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES
Issue
ISSN
1941-7705